Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,231 | 905 | 75.8% |
| Travel and Lodging | $6,126 | 30 | 24.2% |
| Education | $5.12 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $5,220 | 214 | $0 (2024) |
| Nevro Corp. | $4,371 | 113 | $0 (2024) |
| Boston Scientific Corporation | $3,680 | 82 | $0 (2024) |
| SI-BONE, INC. | $1,761 | 22 | $0 (2024) |
| Spinal Simplicity, LLC | $1,439 | 10 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $1,164 | 83 | $0 (2024) |
| Curonix LLC | $1,045 | 13 | $0 (2024) |
| Daiichi Sankyo Inc. | $617.89 | 43 | $0 (2019) |
| SPR Therapeutics, Inc | $512.16 | 16 | $0 (2024) |
| US WorldMeds, LLC | $507.71 | 25 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,891 | 83 | Spinal Simplicity, LLC ($1,439) |
| 2023 | $1,571 | 43 | Abbott Laboratories ($312.35) |
| 2022 | $2,533 | 122 | Abbott Laboratories ($1,136) |
| 2021 | $2,719 | 140 | Abbott Laboratories ($1,206) |
| 2020 | $2,011 | 112 | Abbott Laboratories ($874.59) |
| 2019 | $4,464 | 176 | Boston Scientific Corporation ($1,205) |
| 2018 | $4,788 | 141 | Nevro Corp. ($1,995) |
| 2017 | $2,385 | 120 | BOSTON SCIENTIFIC CORPORATION ($445.48) |
All Payment Transactions
937 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Neuromodulation | ||||||
| 12/16/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: Neuromodulation | ||||||
| 12/12/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Neuromodulation | ||||||
| 12/10/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $23.19 | General |
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: AMANTADINE | ||||||
| 11/14/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $107.72 | General |
| 11/12/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.02 | General |
| Category: Opioid Analgesic | ||||||
| 11/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $77.38 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/09/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $78.59 | General |
| Category: Pain management | ||||||
| 11/07/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Food and Beverage | In-kind items and services | $149.50 | General |
| Category: SPINAL HARDWARE | ||||||
| 10/30/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: Immunology and Neurology | ||||||
| 10/30/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Analgesic | ||||||
| 10/29/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Neuromodulation | ||||||
| 10/29/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: Neuromodulation | ||||||
| 10/09/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: Pain management | ||||||
| 10/02/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.40 | General |
| Category: NEUROLOGY | ||||||
| 09/28/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $19.75 | General |
| Category: Pain management | ||||||
| 09/27/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $22.65 | General |
| Category: Pain management | ||||||
| 09/27/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $4.75 | General |
| Category: Pain management | ||||||
| 09/26/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $4.81 | General |
| Category: Pain management | ||||||
| 09/11/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.86 | General |
| Category: Opioid Analgesic | ||||||
| 09/09/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/28/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.08 | General |
| Category: Opioid Analgesic | ||||||
| 08/24/2024 | Spinal Simplicity, LLC | HA MINUTEMAN G3-R (Device) | Food and Beverage | In-kind items and services | $3.76 | General |
| Category: SPINAL HARDWARE | ||||||
| 08/23/2024 | Spinal Simplicity, LLC | LIBERTY SI (Device), HA MINUTEMAN G3-R | Travel and Lodging | In-kind items and services | $200.94 | General |
| Category: SPINAL HARDWARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 731 | 1,650 | $317,178 | $79,026 |
| 2022 | 23 | 1,385 | 2,569 | $763,213 | $230,275 |
| 2021 | 21 | 1,392 | 2,718 | $637,830 | $184,648 |
| 2020 | 21 | 925 | 1,445 | $423,187 | $109,112 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 41 | 60 | $76,507 | $12,844 | 16.8% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 52 | 53 | $31,600 | $10,160 | 32.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 27 | 65 | $36,630 | $9,177 | 25.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 17 | 28 | $33,981 | $8,852 | 26.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 33 | 46 | $32,896 | $8,176 | 24.9% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 26 | 64 | $18,138 | $4,844 | 26.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 15 | 26 | $13,523 | $4,790 | 35.4% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 26 | 31 | $21,476 | $4,462 | 20.8% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 64 | 66 | $10,272 | $3,959 | 38.5% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 14 | 21 | $11,615 | $3,055 | 26.3% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 13 | 13 | $6,107 | $1,842 | 30.2% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 14 | 21 | $5,727 | $1,594 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 16 | $5,025 | $1,560 | 31.1% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 12 | 18 | $4,855 | $1,534 | 31.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 77 | 189 | $1,591 | $1,120 | 70.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 64 | 82 | $3,189 | $799.00 | 25.1% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 55 | 374 | $3,370 | $185.45 | 5.5% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 38 | 160 | $75.20 | $49.71 | 66.1% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 59 | 158 | $66.96 | $18.60 | 27.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 25 | 28 | $10.08 | $2.70 | 26.8% |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | Office | 2023 | 46 | 131 | $524.00 | $1.97 | 0.4% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 339 | 541 | $321,291 | $104,481 | 32.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 351 | 564 | $87,243 | $33,924 | 38.9% |
| 64640 | Destruction of peripheral nerve or branch | Office | 2022 | 22 | 137 | $53,526 | $16,545 | 30.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 39 | 55 | $69,813 | $12,237 | 17.5% |
About Dr. Daniel Salcedo, MD
Dr. Daniel Salcedo, MD is a Physical Medicine & Rehabilitation healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346220803.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Salcedo, MD has received a total of $25,362 in payments from pharmaceutical and medical device companies, with $4,891 received in 2024. These payments were reported across 937 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($19,231).
As a Medicare-enrolled provider, Salcedo has provided services to 4,433 Medicare beneficiaries, totaling 8,382 services with total Medicare billing of $603,061. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Williamsville, NY
- Active Since 01/20/2006
- Last Updated 03/07/2023
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1346220803
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $3,304
- SPECTRA WAVEWRITER (Device) $2,631
- HA MINUTEMAN G3-R (Device) $1,119
- Proclaim Family of SCS IPGs (Device) $1,064
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $1,045
- Neuromodulation Dspsbls and Accs (Device) $1,019
- OCTRODE (Device) $1,014
- IFUSE IMPLANT SYSTEM (Device) $920.16
- Proclaim IPG (Device) $702.23
- XTAMPZA (Drug) $693.42
- Omnia (Device) $576.06
- WaveWriter Alpha Prime 16 (Device) $530.70
- SPRINT PNS System (Device) $512.16
- Proclaim DRG IPG (Device) $503.45
- Senza (Device) $490.19
- Morphabond ER (Drug) $466.30
- NURTEC ODT (Drug) $401.40
- PROCLAIM (Device) $371.87
- iFuse Implant (Device) $370.96
- Aimovig (Biological) $356.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Williamsville
Dr. Jafar Siddiqui, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $62,989
Michael Cicchetti, Md, MD
Physical Medicine & Rehabilitation — Payments: $22,533
Dr. Leonard Kaplan, Do, DO
Physical Medicine & Rehabilitation — Payments: $18,183
Dr. Corine Cicchetti, Md, MD
Physical Medicine & Rehabilitation — Payments: $13,944
Dr. Frederick Mcadam, Md, MD
Physical Medicine & Rehabilitation — Payments: $6,133
Dr. Michael Geraci, Md, MD
Physical Medicine & Rehabilitation — Payments: $4,277